| | | |
 |
2023 MMM Multi Language Insert.pdf
| 11/22/2022 8:13:57 AM | 427.1 KB |
 |
2023 OTC NDC Reference File.pdf
| 12/20/2022 11:10:17 AM | 2.34 MB |
 |
MC23-001-MPD Comunicado MSO-PHA-LET-1284-010323-S Solicitud de Tarjetas del Plan a los afiliados de MMM.pdf
| 1/4/2023 1:32:57 PM | 233.01 KB |
 |
MC23-002-CG - Recordatorio Notificacion de Cambios Operacionales.pdf
| 1/12/2023 7:31:01 AM | 138.67 KB |
 |
MC23-003-CG Recordatorio Procesamiento y Adjudicacion de Reclamaciones de Farmacia para MAPFRE.pdf
| 1/12/2023 8:43:45 AM | 117.07 KB |
 |
MC23-004-CG FDA Spectrum recall 3 lots of Epinephrine (L-Adrenaline) USP due to product discolored.pdf
| 1/12/2023 9:45:30 AM | 79.09 KB |
 |
MC23-005-CG Farmacéuticos certificados pueden administrar vacunas de rutina sin orden médica.pdf
| 1/12/2023 10:33:41 AM | 94.67 KB |
 |
MC23-006-MPD Controles de Seguridad y Protocolos para el Monitoreo del Uso de Opioides.pdf
| 1/16/2023 8:13:31 AM | 86.29 KB |
 |
MC23-007-CG Programa Educativo de MC-Rx - Conocimiento de Biosimilares.pdf
| 1/19/2023 7:35:42 AM | 812.81 KB |
 |
MC23-008-CG Extension Almacenamiento Tratamientos de COVID-19 Paxlovid, Evusheld y Molnupiravir.pdf
| 1/26/2023 3:08:15 PM | 442.44 KB |
 |
MC23-009-CG Lista de la fecha de expiración actualizada para lotes de Paxlovid distribuidos.pdf
| 1/27/2023 2:09:56 PM | 333.47 KB |
 |
MC23-010-MPD Recordatorio - Notificacion Estandar CMS-10147 sobre derechos y cobertura beneficiarios MPD.pdf
| 2/1/2023 8:41:21 AM | 362.68 KB |
 |
MC23-011-CG FDA IBSA recall 27 lots TIROSINT-SOL (levothyroxine sodium) Oral Solution due to subpotency.pdf
| 2/2/2023 1:45:33 PM | 100.95 KB |
 |
MC23-012-CG FDA Global recall all lots Artificial Tears Lubricant Eye Drops.pdf
| 2/6/2023 7:08:44 AM | 85.83 KB |
 |
MC23-013-MPD COMUNICACION IMPORTANTE SOBRE EL DESPACHO DE LANTUS E INSULIN GLARGINE-YFGN EP.pdf
| 2/22/2023 7:15:22 AM | 96.66 KB |
 |
MC23-014-CG Charla Productos Biosimilares Aspectos Importantes en su Despensacion e Intercambio.pdf
| 2/22/2023 8:00:12 AM | 125.81 KB |
 |
MC23-015-CG FDA Apotex Recall 6 lots Brimonidine Tartrate Ophthalmic Solution, 0.15.pdf
| 3/23/2023 11:56:18 AM | 135.67 KB |
 |
MC23-016-CG MC-Rx Volumen 58 - Marzo 2023 - Medicamentos Pediátricos manejo resfriado, tos y dolor.pdf
| 3/8/2023 2:59:07 PM | 236.19 KB |
 |
MC23-017-MPD Medicare Part D Compliance Requirements - OIG GSA - Attestation Form.pdf
| 3/23/2023 12:11:03 PM | 71.06 KB |
 |
MC23-018-CG FDA Ascend recall Dabigatran Etexilate Caps USP 75 mg and 150 mg due to nitrosamine.pdf
| 3/24/2023 12:04:52 PM | 93.81 KB |
 |
MC23-019-MPD Busqueda de Elegibilidad - Nueva Funcionalidad en InnovaMD.pdf
| 3/28/2023 10:41:26 AM | 1.11 MB |
 |
MC23-020-CG Recordatorio Notificacion de Cambios Operacionales.pdf
| 4/3/2023 8:46:44 AM | 139.07 KB |
 |
MC23-021-CG Recordatorio Procesamiento y Adjudicacion de Reclamaciones de Farmacia para MAPFRE.pdf
| 4/3/2023 9:23:37 AM | 117.01 KB |
 |
MC23-022-MPD Recordatorio - Notificacion Estandar CMS-10147 sobre derechos y cobertura beneficiarios MPD.pdf
| 4/3/2023 11:48:46 AM | 363.08 KB |
 |
MC23-023-CG FDA Camber recall 1 lot Atovaquone Oral Suspension USP 750mg 5mL due to Bacillus cereus.pdf
| 4/3/2023 1:49:33 PM | 88.22 KB |
 |
MC23-024-CG FDA Commissioner and Chief Scientist Announce Decision to Withdraw Approval of Makena.pdf
| 4/6/2023 4:41:09 PM | 76.16 KB |
 |
MC23-025-CG FDA Update Prescribing Info to Provide Guidance for Safe Use All Opioid Pain Medicine.pdf
| 4/14/2023 1:21:11 PM | 105.84 KB |
 |
MC23-026-CG FDA Teva recall Specific Lots of FENTANYL Buccal Tablets CII Due to a Labeling Error.pdf
| 5/1/2023 11:49:58 AM | 89.94 KB |
 |
MC23-027-CG Declaracion de Divulgacion (Disclosure Statement) 2023.pdf
| 5/4/2023 2:36:59 PM | 114.06 KB |
 |
MC23-028-CG FDA Akorn recall various within-expiry human and animal products due to company shutdown.pdf
| 5/8/2023 10:21:07 AM | 645.67 KB |
 |
MC23-029-CG MCRx Informative Series, Volume 59 May 2023 Biosimilar Knowledge - Biosimilars Are Safe.pdf
| 5/11/2023 3:59:45 PM | 259.01 KB |
 |
MC23-031-CG FDA Update Warnings to Improve Safe Use of Prescription Stimulants Used to Treat ADHD.pdf
| 5/26/2023 4:11:12 PM | 109.47 KB |
 |
MC23-032-MPD Comunicacion Importante Despacho Lantus, Glargine-YFGN, Rezvoglar, Humalog y Lispro.pdf
| 6/6/2023 10:52:08 AM | 194.94 KB |
 |
MC23-033-CG FDA Harvard Drug recall 1 lot Dronabinol Caps USP 2.5mg and Ziprasidone HCL Caps 20mg.pdf
| 6/16/2023 1:49:34 PM | 182.91 KB |
 |
MC23-034-MPD Comunicado de MMM sobre actualización del programa de Medicamentos OTC.pdf
| 6/26/2023 3:42:51 PM | 239.78 KB |
 |
MC23-035-CG Recordatorio Notificacion de Cambios Operacionales.pdf
| 7/3/2023 9:51:47 AM | 138.66 KB |
 |
MC23-036-CG Recordatorio Procesamiento y Adjudicacion de Reclamaciones de Farmacia para MAPFRE.pdf
| 10/2/2023 3:50:16 PM | 128.62 KB |
 |
MC23-037-MPD Recordatorio - Notificacion Estandar CMS-10147 sobre derechos y cobertura beneficiarios MPD.pdf
| 7/3/2023 1:29:24 PM | 363.16 KB |
 |
MC23-038-CG FDA Cipla recall 6 batches Albuterol Sulfate Inhalation Aerosol, 90 mcg.pdf
| 7/7/2023 4:38:49 PM | 90.3 KB |
 |
MC23-039-MPD Sistema de Procesamiento de CVS.pdf
| 7/10/2023 4:40:16 PM | 70.76 KB |
 |
MC23-040-MPD MMM Adjudicación de Reclamaciones - Procedimientos de reprocesamiento del sistema.pdf
| 7/11/2023 2:30:49 PM | 75.91 KB |
 |
MC23-041-CG Recordatorio Declaracion de Divulgacion (Disclosure Statement) 2023.pdf
| 7/13/2023 8:05:36 AM | 116.58 KB |
 |
MC23-042-CG Tarjeta de Descuento en Medicamentos de SHRM.pdf
| 8/1/2023 3:49:48 PM | 152.19 KB |
 |
MC23-043-CG FDA Lupin recall 2 lots Tydemy Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tabs.pdf
| 8/3/2023 3:19:10 PM | 88.43 KB |
 |
MC23-044-MPD MMM - Vacunas Cubiertas por Medicare - Servicios Preventivos de Vacunación.pdf
| 8/9/2023 3:09:30 PM | 118.31 KB |
 |
MC23-045-CG Programa Educativo de MC-Rx - Cómo Identificar Un Genérico Autorizado.pdf
| 8/14/2023 10:10:53 AM | 927.77 KB |
 |
MC23-046-CG MCRx Inf Series Vol 60 Sep 2023 Medication Precautions Patients Chronic Kidney Disease.pdf
| 8/31/2023 2:53:03 PM | 231.36 KB |
 |
MC23-047-CG FDA Marlex recall Digoxin Tabs USP, 0.125mg and 0.25mg Due to Label Mix-Up.pdf
| 9/1/2023 1:28:52 PM | 86.21 KB |
 |
MC23-048-CG CONWASTE - MC-Rx Nuevo Administrador de Cubierta de Farmacia.pdf
| 9/6/2023 3:05:47 PM | 85.87 KB |
 |
MC23-049-CG FDA Novartis recall 1 Lot Sandimmune Oral Sol (Cyclosporine) 100 mgmL due crystallization.pdf
| 9/12/2023 10:23:09 AM | 87.83 KB |
 |
MC23-050-CG RECORDATORIO - MC-Rx Nuevo Administrador Cubierta Farmacia CONWASTE a partir 1 octubre.pdf
| 9/21/2023 10:54:27 AM | 94.66 KB |
 |
MC23-051-CG FDA change therapeutic equivalence rating for Accord generics Prograf oral caps.pdf
| 9/22/2023 10:44:20 AM | 199.09 KB |
 |
MC23-052-CG FDA VistaPharm recall 1 lot Sucralfate Oral Suspension 1g10mL due to Bacillus.pdf
| 9/26/2023 8:33:33 AM | 84.48 KB |
 |
MC23-053-CG RECORDATORIO - MC-Rx Nuevo Administrador Cubierta Farmacia CONWASTE a partir 1 octubre.pdf
| 9/28/2023 10:32:49 AM | 94.66 KB |
 |
MC23-054-CG FDA SCYNEXIS recall 2 lots BREXAFEMME (ibrexafungerp tablets) due to cross contamination.pdf
| 9/29/2023 10:35:56 AM | 87.33 KB |
 |
MC23-055-CG Recordatorio Notificacion de Cambios Operacionales.pdf
| 10/2/2023 11:36:39 AM | 138.51 KB |
 |
MC23-056-CG RECORDATORIO - MC-Rx Nuevo Administrador Cubierta Farmacia CONWASTE a partir 1 octubre.pdf
| 10/2/2023 2:16:33 PM | 94.62 KB |
 |
MC23-057-CG Recordatorio Procesamiento y Adjudicacion de Reclamaciones de Farmacia para MAPFRE.pdf
| 10/2/2023 3:41:31 PM | 128.65 KB |
 |
MC23-058-MPD Recordatorio - Notificacion Estandar CMS-10147 sobre derechos y cobertura beneficiarios MPD.pdf
| 10/2/2023 4:31:38 PM | 367.37 KB |
 |
MC23-059-CG FDA KVK-Tech recall 1 lot Betaxolol Tablets USP 10mg due to foreign tablet found on packaging.pdf
| 10/4/2023 3:34:02 PM | 116.85 KB |
 |
MC23-060-CG Recordatorio Declaracion de Divulgacion (Disclosure Statement) 2023.pdf
| 10/6/2023 10:58:20 AM | 116.78 KB |
 |
MC23-061-CG Tarjeta de Descuento en Medicamentos de SHRM.pdf
| 11/9/2023 1:24:50 PM | 152.64 KB |
 |
MC23-062-CG FDA Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mgmL Due to Presence of Microbial Contamination.pdf
| 11/22/2023 12:35:04 PM | 855.98 KB |
 |
MC23-063-CG Tarjeta de Descuento en Medicamentos de GeneraPR.pdf
| 11/28/2023 11:40:07 AM | 1.4 MB |
 |
MC23-064-CG FDA Novartis issues recall of Sandimmune Solution 100 mgmL due to crystal formation.pdf
| 11/28/2023 11:40:22 AM | 930.52 KB |
 |
MC23-065-CG FDA Drug Safety Communication - FDA Warns of Rare but Serious Drug Reaction .pdf
| 12/1/2023 11:20:50 AM | 884.97 KB |
 |
MC23-066-CG MCRx Informative Series, Volume 61, Dic 2023, Safe Storage and Disposal of Medications.pdf
| 12/12/2023 8:32:32 AM | 223.48 KB |
 |
MC23-067-CG FDA InvaGen Recall 1 lot Vigabatrin for Oral Solution USP 500mg due to Leaking Sachets.pdf
| 12/13/2023 9:11:43 AM | 87.08 KB |